Articles by Jeanna Holtz
-
Tuesday
July 28
2015When ‘Wonder Drugs’ Aren’t Enough: Viral hepatitis reaches watershed moment, but who will pay?
Debate rages about what constitutes fair pricing practices for a lifesaving drug that could save millions of people – and how to balance affordability and access with sustained investment in R&D, company profits and responsiveness to stakeholders including patients, health care providers, payers and shareholders.
- Categories
- Health Care
-
Monday
April 27
2015NCDs Threatening Health Insurance: Innovations, partnerships offer ways to mitigate the impact
Non-communicable diseases have become the leading cause of death and disability worldwide?, carrying immense implications for insurance programs. However, ?there are opportunities? for public and private insurers to create and expand disease detection and management systems to mitigate the incidence and effect of NCDs.
- Categories
- Health Care